title: Phase II study of FK 506 for allogeneic bone marrow transplantation.
authors.affiliation: Fifth Department of Internal Medicine, Center for Adult Diseases, Osaka, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Masaoka
authors.forename: H
authors.initials: H
authors.lastname: Shibata
authors.forename: E
authors.initials: E
authors.lastname: Kakishita
authors.forename: A
authors.initials: A
authors.lastname: Kanamaru
authors.forename: Y
authors.initials: Y
authors.lastname: Takemoto
authors.forename: Y
authors.initials: Y
authors.lastname: Moriyama
mesh_terms: D000208:Acute Disease; D000328:Adult; D016026:Bone Marrow Transplantation / Q000276:immunology*; D002908:Chronic Disease; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use; D003967:Diarrhea / Q000139:chemically induced; D004341:Drug Evaluation; D005260:Female; D006086:Graft vs Host Disease / Q000188:drug therapy*; D006801:Humans; D008297:Male; D016559:Tacrolimus / Q000627:therapeutic use / Q000633:toxicity*; D014184:Transplantation, Homologous
chemical_list: D016572:Cyclosporine; D016559:Tacrolimus